Krewel Meuselbach
LeaveRussia detail: Exit Completed
Krewel Meuselbach GmbH is a German, owner-operated pharmaceutical company known for producing high-quality herbal medicines (phyto-pharmaceuticals) and conventional drugs, manufacturing in Germany (Eitorf & Gehren) for global markets, specializing in liquid/solid forms like syrups and tablets, and offering contract manufacturing. Established from the merger of Krewel Werke (est. 1893) and Meuselbach, they focus on holistic therapy with herbal alternatives and modern pharmaceutical development, serving customers in over 20 countries.
Decision trail
Decision date 25/11/2025 · Reference ↗
Received revenues in Russia in 2022-2024. Revenue decreased in 2024 vs 2023 by more than -10%. 25.11.2025: Dr. Theiss Naturvaren GmbH becomes the new founder of KREVEL MEUSELBACH LLC. KREVEL MEUSELBACH GmbH has been removed from the Unified State Register of Legal Entities.
Local stats (LeaveRussia)
Status history since 2022
- 03/08/2026 — exited · Imported from KSE LeaveRussia
Exposure profile
Full exposure profile is a Professional feature
Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.
Upgrade to Professional